Tacrolimus is a potent immunosuppressant that inhibits cytokine synthesis and blocks T-cell development. Optic neuropathy from tacrolimus toxicity is very uncommon with only a few case reports in the literature. We report three cases of tacrolimus optic neuropathy following bone marrow transplant complicated by graft versus host disease. These three cases demonstrate differing clinical and radiologic presentations of tacrolimus optic neuropathy
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
To characterize the clinical syndrome of acute optic neuropathy and retinopathy following bone marro...
Tacrolimus is routinely used to prevent rejection after organs' transplantation. Neurotoxicity is un...
Intrduction. Tacrolimus (fujimycin or FK506) is a potent immunosuppressive drug with growing usag...
Tacrolimus is currently the most commonly prescribed immunosuppressant. Tacrolimus allowed intestina...
Introduction. Optic neuropathy is a rare but severe complication of tacrolimus treatment. We present...
(1) Background: Tacrolimus is an immunosuppressive agent commonly used in the management of solid or...
Tacrolimus is widely used immunosuppressant and though neurotoxicity is well recognized as a side ef...
internuclear ophthalmoplegia developed in a 30-year-old woman 84 days after she received a matched, ...
This PowerPoint slide deck will describe tacrolimus optic neuropathy which is a very rare form of op...
Purpose: To report a case of asymmetric bilateral optic neuropathy in a patient receiving tacrolimus...
Tacrolimus (FK506) is an immunosuppressant agent in use since 1984 to prevent graft rejection follow...
Renal transplantasyon sonrası takrolimus kullanan hastada ge-lişen bilateral optik nöropati ve tek t...
Tacrolimus is an immunosuppressive agent that inhibitscytokine synthesis and blocks T-cell developme...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
To characterize the clinical syndrome of acute optic neuropathy and retinopathy following bone marro...
Tacrolimus is routinely used to prevent rejection after organs' transplantation. Neurotoxicity is un...
Intrduction. Tacrolimus (fujimycin or FK506) is a potent immunosuppressive drug with growing usag...
Tacrolimus is currently the most commonly prescribed immunosuppressant. Tacrolimus allowed intestina...
Introduction. Optic neuropathy is a rare but severe complication of tacrolimus treatment. We present...
(1) Background: Tacrolimus is an immunosuppressive agent commonly used in the management of solid or...
Tacrolimus is widely used immunosuppressant and though neurotoxicity is well recognized as a side ef...
internuclear ophthalmoplegia developed in a 30-year-old woman 84 days after she received a matched, ...
This PowerPoint slide deck will describe tacrolimus optic neuropathy which is a very rare form of op...
Purpose: To report a case of asymmetric bilateral optic neuropathy in a patient receiving tacrolimus...
Tacrolimus (FK506) is an immunosuppressant agent in use since 1984 to prevent graft rejection follow...
Renal transplantasyon sonrası takrolimus kullanan hastada ge-lişen bilateral optik nöropati ve tek t...
Tacrolimus is an immunosuppressive agent that inhibitscytokine synthesis and blocks T-cell developme...
INTRODUCTION: Tacrolimus is routinely used to prevent rejection after organs’ transplantation. Neuro...
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side ef...
To characterize the clinical syndrome of acute optic neuropathy and retinopathy following bone marro...
Tacrolimus is routinely used to prevent rejection after organs' transplantation. Neurotoxicity is un...